These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 12552242

  • 1. Impaired hepatic mitochondrial oxidation using the 13C-methionine breath test in patients with macrovesicular steatosis and patients with cirrhosis.
    Spahr L, Negro F, Leandro G, Marinescu O, Goodman KJ, Rubbia-Brandt L, Jordan M, Hadengue A.
    Med Sci Monit; 2003 Jan; 9(1):CR6-11. PubMed ID: 12552242
    [Abstract] [Full Text] [Related]

  • 2. [13C]Methionine breath test: a novel method to detect antiretroviral drug-related mitochondrial toxicity.
    Milazzo L, Piazza M, Sangaletti O, Gatti N, Cappelletti A, Adorni F, Antinori S, Galli M, Moroni M, Riva A.
    J Antimicrob Chemother; 2005 Jan; 55(1):84-9. PubMed ID: 15590719
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [The 13C-methacetin breath test for quantitative noninvasive liver function analysis with an isotope-specific nondispersive infrared spectrometer in liver cirrhosis].
    Pfaffenbach B, Götze O, Szymanski C, Hagemann D, Adamek RJ.
    Dtsch Med Wochenschr; 1998 Dec 04; 123(49):1467-71. PubMed ID: 9861887
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Utility of a 13C-methacetin breath test in evaluating hepatic injury in rats.
    Shirin H, Aeed H, Shalev T, Sorin V, Stavinski S, Shahmurov M, Ilan Y, Avni Y.
    J Gastroenterol Hepatol; 2008 Nov 04; 23(11):1762-8. PubMed ID: 19120861
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 13CO2 excretion in breath of normal subjects and cirrhotic patients after 13C-aminopyrine oral load. Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis.
    Fasoli A, Giannini E, Botta F, Romagnoli P, Risso D, Celle G, Testa R.
    Hepatogastroenterology; 2000 Nov 04; 47(31):234-8. PubMed ID: 10690614
    [Abstract] [Full Text] [Related]

  • 10. 13C-methacetin breath test as liver function test in patients with chronic hepatitis C virus infection.
    Braden B, Faust D, Sarrazin U, Zeuzem S, Dietrich CF, Caspary WF, Sarrazin C.
    Aliment Pharmacol Ther; 2005 Jan 15; 21(2):179-85. PubMed ID: 15679768
    [Abstract] [Full Text] [Related]

  • 11. Aminopyrine breath test: development of a 13C-breath test for quantitative assessment of liver function in humans.
    Mion F, Queneau PE, Rousseau M, Brazier JL, Paliard P, Minaire Y.
    Hepatogastroenterology; 1995 Jan 15; 42(6):931-8. PubMed ID: 8847048
    [Abstract] [Full Text] [Related]

  • 12. Non-invasive estimation of liver fibrosis in non-alcoholic fatty liver disease using the 13 C-caffeine breath test.
    Park GJ, Wiseman E, George J, Katelaris PH, Seow F, Fung C, Ngu MC.
    J Gastroenterol Hepatol; 2011 Sep 15; 26(9):1411-6. PubMed ID: 21557768
    [Abstract] [Full Text] [Related]

  • 13. Noninvasive diagnosis and prognosis of liver cirrhosis: a comparison of biological scores, elastometry, and metabolic liver function tests.
    Forestier J, Dumortier J, Guillaud O, Ecochard M, Roman S, Boillot O, Lutringer D, Scoazec JY, Subtil F, Mion F.
    Eur J Gastroenterol Hepatol; 2010 May 15; 22(5):532-40. PubMed ID: 20164779
    [Abstract] [Full Text] [Related]

  • 14. 13C-methacetin and 13C-galactose breath tests can assess restricted liver function even in early stages of primary biliary cirrhosis.
    Holtmeier J, Leuschner M, Schneider A, Leuschner U, Caspary WF, Braden B.
    Scand J Gastroenterol; 2006 Nov 15; 41(11):1336-41. PubMed ID: 17060128
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 13C-methacetin breath test shortened: 2-point-measurements after 15 minutes reliably indicate the presence of liver cirrhosis.
    Schneider A, Caspary WF, Saich R, Dietrich CF, Sarrazin C, Kuker W, Braden B.
    J Clin Gastroenterol; 2007 Jan 15; 41(1):33-7. PubMed ID: 17198062
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Methodological characterization of the 2-keto [1-13C]isocaproate breath test to measure in vivo human mitochondrial function: application in alcoholic liver disease assessment.
    Parra D, González A, García-Villarreal L, Martínez JA.
    Alcohol Clin Exp Res; 2003 Aug 15; 27(8):1293-8. PubMed ID: 12966324
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Disease- and treatment-related predictors of hepatic mitochondrial dysfunction in chronic HIV infection assessed by non-invasive (13)C-methionine breath test diagnostic.
    Banasch M, Knyhala K, Kollar S, Serova K, Potthoff A, Schlottmann R, Schmidt WE, Brockmeyer NH, Goetze O.
    Eur J Med Res; 2008 Sep 22; 13(9):401-8. PubMed ID: 18948231
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.